Profounda receives FDA Orphan Drug Designation for miltefosine for treating Primary Amebic Meningoencephalitis (PAM)
Profounda, Inc. announced Friday that it has received, the US Food and Drug Administration’s (FDA) Orphan Drug Designation for the treatment of Primary Amebic Meningoencephalitis (PAM) with miltefosine. More...
Katie Couric to feature Naegleria survivor, Kali Hardig in October
UPDATE 10-7-13: It has been confirmed that Kali Hardig will be featured on Katie on Thursday, Oct. 10. Kali Hardig, the 12-year-old miracle from Benton, Arkansas, who has captured the hearts of people across More...
Neti Pots, Naegleria and You
After two reported deaths in Louisiana this year from “brain-eating amoebas” after using neti pots, health authorities and the manufacturer of nasal wash device are warning the public not to use unsterilized More...
